IRAK2_PONAB
ID IRAK2_PONAB Reviewed; 625 AA.
AC Q5R810;
DT 06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT 21-DEC-2004, sequence version 1.
DT 03-AUG-2022, entry version 73.
DE RecName: Full=Interleukin-1 receptor-associated kinase-like 2;
DE Short=IRAK-2;
GN Name=IRAK2;
OS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Pongo.
OX NCBI_TaxID=9601;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Kidney;
RG The German cDNA consortium;
RL Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Binds to the IL-1 type I receptor following IL-1 engagement,
CC triggering intracellular signaling cascades leading to transcriptional
CC up-regulation and mRNA stabilization. {ECO:0000250}.
CC -!- SUBUNIT: Interacts with MYD88. IL-1 stimulation leads to the formation
CC of a signaling complex which dissociates from the IL-1 receptor
CC following the binding of PELI1 (By similarity). {ECO:0000250}.
CC -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC inactive.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC protein kinase family. Pelle subfamily. {ECO:0000305}.
CC -!- CAUTION: Asn-335 is present instead of the conserved Asp which is
CC expected to be an active site residue. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CR859945; CAH92100.1; -; mRNA.
DR AlphaFoldDB; Q5R810; -.
DR SMR; Q5R810; -.
DR STRING; 9601.ENSPPYP00000015274; -.
DR eggNOG; KOG1187; Eukaryota.
DR InParanoid; Q5R810; -.
DR Proteomes; UP000001595; Unplaced.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IEA:InterPro.
DR GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR GO; GO:0070498; P:interleukin-1-mediated signaling pathway; IEA:InterPro.
DR GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; IEA:InterPro.
DR GO; GO:0044093; P:positive regulation of molecular function; IEA:UniProt.
DR GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR GO; GO:0031326; P:regulation of cellular biosynthetic process; IEA:UniProt.
DR GO; GO:0001959; P:regulation of cytokine-mediated signaling pathway; IEA:InterPro.
DR GO; GO:0010468; P:regulation of gene expression; IEA:UniProt.
DR GO; GO:0010556; P:regulation of macromolecule biosynthetic process; IEA:UniProt.
DR CDD; cd08795; Death_IRAK2; 1.
DR Gene3D; 1.10.533.10; -; 1.
DR InterPro; IPR011029; DEATH-like_dom_sf.
DR InterPro; IPR000488; Death_domain.
DR InterPro; IPR042151; Death_IRAK2.
DR InterPro; IPR033611; IRAK2.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR000719; Prot_kinase_dom.
DR PANTHER; PTHR24419:SF2; PTHR24419:SF2; 1.
DR Pfam; PF00531; Death; 1.
DR Pfam; PF00069; Pkinase; 1.
DR SUPFAM; SSF47986; SSF47986; 1.
DR SUPFAM; SSF56112; SSF56112; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE 2: Evidence at transcript level;
KW ATP-binding; Nucleotide-binding; Phosphoprotein; Reference proteome.
FT CHAIN 1..625
FT /note="Interleukin-1 receptor-associated kinase-like 2"
FT /id="PRO_0000277561"
FT DOMAIN 13..94
FT /note="Death"
FT DOMAIN 210..503
FT /note="Protein kinase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT REGION 111..181
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 513..539
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 115..129
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 166..181
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 515..539
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 216..224
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 237
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 337..340
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT MOD_RES 144
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43187"
SQ SEQUENCE 625 AA; 69578 MW; 6D25A1C184FEF41B CRC64;
MACYIYQLPS WVLDDPCRNM DALSEWDWME FASYVITDLT QLRKIKSMER VQGVSITREL
LWWWGMRQAT VRQLVDLLCR LELYRAAQII LNWKPAPEIR CPIPAFPDSV KPEKPLAASV
KKAENEQEEG QPVRMATFPG PGSSPARAHQ PAFLQPPEED APHSLRTDLP TSSDSKDFST
SIPKQEKLLS LAGDSLFWSE ADVVQATDDF NQNHKISQGT FADVYRGYRH GTPFVFKKLR
ETACSSPGSI ERFFQAELQI CLRCCHPNVL PVLGFCAARQ FHSFIYPYMA NGSLQDRLQG
QGGSDPLPWP QRVSICSGLL CAVEYLHGLE IIHSNVKSSN VLLDQNLTPK LAHPMAHLCP
VNKRSKYTMM KTHLFRTSAA YLPEDFIRVG QLTKRVDIFS CGIVLAEVLT GIPAMDNNRS
PVYLKDLLLS EIPSSTASPC SRKTGVENVM AKEICQKYLE KGAGRLPEDC AEALATAACL
CLRKRNTSLQ EVRGSVAAVE EWLRGREMLL PWSGLSEGTG SSSNTPEETD DVDNSSLDAS
SSVSVAPWAG AATPLLPTEN GEGRLRVIVR READSSSEAC VGPEPPQDVT ETSWQIDINE
AKRKLMENIL LYKEEKLDSI ELFGP